Cover Image
市場調查報告書

婦產科診斷檢驗市場:妊娠及排卵、骨骼密度、產前篩檢、超音波、乳房X光攝影、子宮頸抹片檢查、陰道鏡檢查、HPV、UTI、其他

Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)

出版商 Kalorama Information 商品編碼 179570
出版日期 內容資訊 英文 237 Pages
訂單完成後即時交付
價格
Back to Top
婦產科診斷檢驗市場:妊娠及排卵、骨骼密度、產前篩檢、超音波、乳房X光攝影、子宮頸抹片檢查、陰道鏡檢查、HPV、UTI、其他 Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
出版日期: 2014年10月30日 內容資訊: 英文 237 Pages
簡介

本報告提供以女性為對象的各種診斷檢驗的市場相關調查、最新的市場與技術等最新趨勢、主要的檢驗種類與概要、主要疾病區分與各檢驗種類的市場成長預測、企業及企業間的配合措施、主要經營者簡介等彙整資料。

第1章 摘要整理

第2章 簡介

  • 女性的健康:改善的空間
  • 女性的健康相關展望
  • 女性和男性的疾病發病的差異
    • 疼痛
    • 心臟
    • 情趣
    • 骨骼結構
    • 酒精
    • 副作用
    • 抽煙
    • 生殖能力
    • 性感染疾病/HIV
    • 自體免疫疾病
    • 癌症
    • 肌肉骨骼系統
    • 先天異常
    • 泌尿道感染
  • 女性的主要死亡原因
  • 人口統計
  • 女性的生命相關主張
  • 女性的診斷中主要趨勢與課題
    • OVA1
    • CA125
    • HER2
  • 理解疾病的分子性基礎
    • 癌症的管理與償付的成本
    • 超音波及乳房X光攝影的利用擴大

第3章 女性的健康檢查市場發展

  • Quest及Hologic的合作
  • 乳癌風險的Quest的遺傳基因檢驗
  • 非侵入性產前檢查Sequenom及Quest聯盟
  • 聯盟可個體化不孕治療
  • 全長HLA遺傳基因排列產品的聯合行銷
  • 收購強化Theranostics(診斷、治療的融合)的開發
  • Trinity Biotech的收購
  • 非侵入性產前診斷:偽陽性率大幅降低
  • Proteome Sciences和Fisher Scientific在癌症檢驗簽署協議
  • 胎兒、母體的監測軟體相關契約
  • 女性健康的OTC診斷藥相關銷售契約
  • 女性的癌症診斷的經營者,採購1130萬美元
  • 家庭乳癌檢驗設備的群眾集資
  • 女性的尿失禁用設備的FDA 510(k)許可
  • FDA的ABUS的認證
  • 超音波成像軟體系統的FDA的核准
  • 乳房組織篩檢系統的EU認證
  • 子宮頸癌篩檢檢驗相關疑慮
  • 新的智慧型手機應用程式:數分鐘便可檢測新生兒黃疸等

第4章 妊娠及排卵

  • 主要的趨勢
  • 檢驗相關展望
    • 數位檢驗
    • 胎盤生長因子及妊娠毒血症的檢驗
    • 實驗室開發檢驗
  • OTC妊娠自我檢驗市場
  • 檢驗室的妊娠檢驗市場
  • 檢驗室的TORCH症候群檢驗市場
  • Abbott Diagnostics
  • Alere Inc.
  • biomerieux SA
  • Church & Dwight Co. Inc
  • Dialab GMBH
  • Prestige Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics

第5章 骨骼密度檢驗

  • 主要的趨勢
  • 應憂慮骨質疏鬆症增加
  • 推動檢測的需求
  • DEXA與競爭技術
  • 骨質密度檢測設備市場
  • GE Healthcare
  • Hologic
  • Osteometer MediTech

第6章 產前篩檢

  • 主要趨勢
  • 侵入性檢驗
  • 非侵入性檢驗
  • 產前基因檢測的影響
  • DNA化驗市場
  • 產前Carrier、胎兒篩檢市場
  • PerkinElmer
  • Quest Diagnostics
  • ScreenCell
  • Sequenom
  • Laboratory Corporation of America

第7章 超音波

  • 主要趨勢
  • 過程及展望
  • NT(胎兒頸部透明帶)
  • 降低斑點
  • 立體影像
  • 卵泡追蹤
  • 婦產科
  • 乳房撮像
  • 婦科、婦產科市場
  • 乳房攝影篩檢市場
  • Analogic
  • Philips Healthcare
  • Siemens Healthcare
  • GE Healthcare
  • Hitachi Aloka Medical Ltd.
  • Supersonic Imagine

第8章 乳房X光攝影

  • 主要趨勢
  • 展望
  • 定期篩檢檢驗的經濟學
  • 數位化的轉變
  • 電腦支援的偵測
    • 第二意見
    • 腫瘤的特徵分析
  • 乳房X光攝影系統市場
  • CAD市場
  • Carestream Health
  • FujiFilm Medical Systems USA
  • GE Healthcare
  • Hologic
  • iCAD Inc
  • Parascript LLC
  • R2 Technology

第9章 子宮頸抹片檢查

  • 主要趨勢
  • 子宮頸癌症檢查
    • 篩檢的各種類型
  • 子宮頸癌疫苗
  • 市場需求
  • IVD市場
  • BD
  • BioReference Laboratories
  • BioSciCon
  • Hologic
  • Innogenetics NV

第10章 陰道鏡檢查

  • 主要趨勢
  • 陰道鏡切片檢查
  • 異常的子宮頸抹片檢查的結果
  • 定期性利用與成熟市場
    • 一次篩檢和二次篩檢
  • 陰道鏡檢查系統市場
  • CooperSurgical
  • DySIS Medical
  • Guided Therapeutics
  • Leisegang
  • NeoDiagnostix

第11章 HPV檢驗

  • 主要趨勢
  • HPV(人類乳突病毒)感染疾病
    • 女性的感染
    • 高風險型
    • 子宮頸癌的主要原因:HPV
  • HPV檢驗
  • 疫苗的問題
  • 對大市場的期待
  • Abbott Molecular
  • Hologic
  • Qiagen Benelux BV
  • Roche Diagnostics

第12章 卵巢癌

  • 主要趨勢
  • 卵巢癌的類型
  • 婦科檢查
  • 腫瘤標記、AFP、HE4
  • CA-125抗原
  • CA-125市場
  • Avant Diagnostics Inc.
  • Biosystems International
  • Fujirebio Diagnostics
  • Myriad Genetics Inc.

第13章 泌尿道感染

  • 主要趨勢
  • 患病、死亡的主要原因
    • 影響
    • 女性的影響
    • E. 大腸菌:主要的犯人
  • UTI分子檢驗市場
  • i-Health Inc.
  • Liofilchem
  • Rheonix
  • Somagen Diagnostics

第14章 新生兒黃疸

  • 主要趨勢
  • 尿膽紅素相關問題
  • 新生兒的2種要素
  • 風險因素
  • 智慧型手機應用程式
  • 尿膽紅素檢驗市場
  • Instrumentation Laboratory
  • Nova Biomedical
  • Siemens Healthcare Diagnostics
  • 和光純藥工業
  • Roche Diagnostics

第15章 自體免疫疾病

  • 主要趨勢
  • 自體免疫疾病的類型
  • 遺傳基因因素
  • 女性的影響
  • 檢驗室的免疫化驗自體免疫檢驗的市場
  • Aesku.Diagnostics
  • AXA Diagnostics SRL
  • Bio-Rad Laboratories
  • Euroimmun AG
  • Immco Diagnostics
  • Kronus
  • Phadia
  • XDX

第16章 囊狀纖維化症

  • 主要趨勢
  • 全身的影響
  • 平均壽命低
  • 遺傳基因檢驗
  • 慢性感染疾病
  • 比男性有惡化趨勢的女性
  • 遺傳基因檢驗市場
  • AutoGenomics
  • GenMark Diagnostics
  • Illumina
  • Luminex
  • ScheBo-Biotech AG
  • Sequenom

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI5367934

The women's health arena, both therapeutics and diagnostics, has grown considerably as a specialty medical field. Once limited to obstetrics and gynecology, it now includes other fields, such as urology, maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific types of women's health-related testing. Generally, and from a perspective on women's health, diagnostics are playing an ever increasing role.

Worldwide, women are living longer than men. There is a need to improve the understanding of the differences, in terms of health, between the sexes and to translate that knowledge into improved medical diagnostics, practice and therapies.

Kalorama Information's Women's Health Diagnostic Markets analyzes the current and potential world markets for key diagnostic tests targeted at women's health. This report generally forecasts future market growth for these tests to 2018. Market segments covered include the US, Europe, China, Brazil, Japan and rest of world markets.

The report presents market developments in women's health diagnostics, including in-depth analysis of the following testing fields:

  • Pregnancy and Ovulation Testing
  • Bone Density Testing
  • Prenatal Screening
  • Ultrasound
  • Mammography
  • Pap Smears
  • Colposcopy
  • HPV Testing
  • Ovarian Cancer Testing
  • Urinary Tract Infections
  • Neonatal Jaundice
  • Autoimmune Disease
  • Cystic Fibrosis

Over the next few decades, comprehensive genomics-based health care should be the norm in the US and much of Europe. In the next decade, genetic tests will routinely predict individual susceptibility to disease. Diagnoses of many conditions will be much more thorough and specific than now. The report gives insight into understanding the molecular basis of disease.

Women's Health Diagnostic Markets also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. The report profiles several key companies, including large companies that have made names for themselves in the field, as well as smaller firms with market niches. These companies are involved in developing and marketing over the counter (OTC), point of care (POC) in vitro diagnostic (IVD) tests and screening systems. Some of the companies profiled include:

  • GE Healthcare
  • GenMark Diagnostics
  • Hologic
  • Immco Diagnostics
  • Luminex
  • Nova Biomedical
  • Philips Healthcare
  • Siemens Healthcare
  • Somagen Diagnostics

Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data are generated into multiple year forecasts for different product segments covered in the report. The information presented in this report is the result of data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives and researchers.

Table of Contents

1.0 Executive Summary

  • 1.1 Methodology

2.0 Introduction

  • 2.1 Female Health: Room for Improvement
  • 2.2 Perspective on Women's Health
  • 2.3 The Way Women and Men Develop Disease Is Different
    • 2.3.1 Pain
    • 2.3.2 The Heart
    • 2.3.3 The Brain
    • 2.3.4 Emotions
    • 2.3.5 Bone Structure
    • 2.3.6 Alcohol
    • 2.3.7 Drug Side Effects
    • 2.3.8 Smoking
    • 2.3.9 Fertility
    • 2.3.10 STIs/HIV
    • 2.3.11 Autoimmune Disease
    • 2.3.12 Cancer
    • 2.3.13 Musculoskeletal Health
    • 2.3.14 Birth Defects
    • 2.3.15 Urinary Tract Infections
  • 2.4 Key Leading Causes of Death in Females
  • 2.5 Demographics
  • 2.6 What Claims Women's Lives
  • 2.7 Key Trends and Issues in Women's Diagnostics
    • 2.7.1 OVA1
    • 2.7.2 CA-125
    • 2.7.3 HER2
  • 2.8 Understanding the Molecular Basis of Disease
    • 2.8.1 Managing Cancer Disease and Costs through Reimbursement
    • 2.8.2 Ultrasound and Mammography Use Grows

3.0 Market Developments in Women's Health Diagnostics

  • 3.1 Quest and Hologic Team Up
  • 3.2 Quest Genetic Testing for Breast Cancer Risk
  • 3.3 Sequenom, Quest Collaborate on Noninvasive Prenatal Testing
  • 3.4 Partnering to Make Personalized Infertility Treatment Possible
  • 3.5 Co-Marketing of Full-Length HLA Gene Sequencing Products
  • 3.6 Acquisition Strengthens Theranostics Development
  • 3.7 Trinity Biotech Acquisition
  • 3.8 Noninvasive Prenatal Test Significantly Reduces False Positive Rate
  • 3.9 Proteome Sciences, Fisher Scientific Sign Agreement on Cancer Tests
  • 3.10 Agreement on Fetal and Maternal Monitoring Software
  • 3.11 Distribution Agreement for OTC Women's Health Diagnostics
  • 3.12 Women's Health Cancer Diagnostics Company Raises $11.3 Million
  • 3.13 Crowd Funding for At-Home Breast Exam Device
  • 3.14 $13M Series A Round for Ultrasound Fibroid Device
  • 3.15 FDA Clears Femur Fracture Test
  • 3.16 FDA 510(k) Clearance for Female Incontinence Device
  • 3.17 GE PMA for extended labeling for Senographe Mammography
  • 3.18 FDA Clears MicroDose Mammography
  • 3.19 FDA ABUS Approval
  • 3.20 FDA Approval for Imaging Software System for Ultrasound
  • 3.21 EU Nod for Breast Tissue Screening System
  • 3.22 Cervical Cancer Screening Test Concerns
  • 3.23 New Smartphone App Detects Newborn Jaundice in Minutes

4.0 Pregnancy and Ovulation

  • Key Trend
  • 4.1 Perspective on Testing
    • 4.1.1 Digital Testing
    • 4.1.2 Testing for Placental Growth Factor and Pre-eclampsia
    • 4.1.3 Lab Developed Tests
  • 4.2 OTC Pregnancy Self-Test Market
  • 4.3 Lab-Based Fertility Testing Market
  • 4.4 Lab-Based Torch Testing Market
  • 4.5 Abbott Diagnostics
  • 4.6 Alere Inc.
  • 4.7 biomerieux SA
  • 4.8 Church & Dwight Co. Inc
  • 4.9 Dialab GMBH
  • 4.10 Prestige Diagnostics
  • 4.11 Roche Diagnostics
  • 4.12 Siemens Healthcare Diagnostics

5.0 Bone Density Testing

  • Key Trend
  • 5.1 Alarming Rise of Osteoporosis
  • 5.2 Propelling the Need for Detection
  • 5.3 DEXA and Competing Technologies
  • 5.4 Bone Densitometer Market
  • 5.5 GE Healthcare
  • 5.6 Hologic
  • 5.7 Osteometer MediTech

6.0 Prenatal Screening

  • Key Trend
  • 6.1 Invasive Testing
  • 6.2 Noninvasive Testing
  • 6.3 The Impact of Prenatal Genetic Testing
  • 6.4 DNA Assay Market
  • 6.5 Prenatal Carrier and Fetus Screening Market
  • 6.6 PerkinElmer
  • 6.7 Quest Diagnostics
  • 6.8 ScreenCell
  • 6.9 Sequenom
  • 6.10 Laboratory Corporation of America

7.0 Ultrasound

  • Key Trend
  • 7.1 History and Perspective
  • 7.2 Nuchal Translucency
  • 7.3 Speckle Reduction
  • 7.4 Volumetric Imaging
  • 7.5 Follicular Tracking
  • 7.6 Obstetrics and Gynecology
  • 7.7 Breast Imaging
  • 7.8 Ob/Gyn Market
  • 7.9 Breast Imaging Market
  • 7.10 Analogic
  • 7.11 Philips Healthcare
  • 7.12 Siemens Healthcare
  • 7.13 GE Healthcare
  • 7.14 Hitachi Aloka Medical Ltd.
  • 7.15 Supersonic Imagine

8.0 Mammography

  • Key Trend
  • 8.1 Perspective
  • 8.1.1 Economics of Routine Screening
  • 8.2 Transitioning to Digital
  • 8.3 Computer-Aided Detection
    • 8.3.1 A Second Opinion
    • 8.3.2 Analyzing Tumor Characteristics
  • 8.4 Mammography Systems Market
  • 8.5 CAD Market
  • 8.6 Carestream Health
  • 8.7 FujiFilm Medical Systems USA
  • 8.8 GE Healthcare
  • 8.9 Hologic
  • 8.10 iCAD Inc
  • 8.11 Parascript LLC
  • 8.12 R2 Technology

9.0 Pap Smears

  • Key Trend
  • 9.1 Testing for Cervical Cancer
    • 9.1.1 Types of Screening
  • 9.2 Cervical Cancer Vaccines
  • 9.3 A Market Need
  • 9.4 IVD Market
  • 9.5 BD
  • 9.6 BioReference Laboratories
  • 9.7 BioSciCon
  • 9.8 Hologic
  • 9.9 Innogenetics NV

10.0 Colposcopy

  • Key Trend
  • 10.1 Colposcopy Biopsy
  • 10.2 Abnormal Pap Smear Results
  • 10.3 Routine Use But Mature Market
    • 10.3.1 Primary and Secondary Screening
  • 10.4 Colposcopy Systems Market
  • 10.5 CooperSurgical
  • 10.6 DySIS Medical
  • 10.7 Guided Therapeutics
  • 10.8 Leisegang
  • 10.9 NeoDiagnostix

11.0 HPV Testing

  • Key Trend
  • 11.1 HPV Infection
    • 11.1.1 Infection in Females
    • 11.1.2 High Risk Types
    • 11.1.3 HPV Major Cause of Cervical Cancer
  • 11.2 HPV Test
  • 11.3 Vaccine Issues
  • 11.4 Strong Market Expected
  • 11.4.1 IVD Market
  • 11.5 Abbott Molecular
  • 11.6 Hologic
  • 11.7 Qiagen Benelux BV
  • 11.8 Roche Diagnostics

12.0 Ovarian Cancer

  • Key Trend
  • 12.1 Types of Ovarian Cancer
  • 12.2 Pelvic Examinations
  • 12.3 Tumor Markers, AFP, HE4
  • 12.4 CA-125 Antigen
  • 12.5 CA-125 Market
  • 12.6 Avant Diagnostics Inc.
  • 12.7 Biosystems International
  • 12.8 Fujirebio Diagnostics
  • 12.9 Myriad Genetics Inc.

13.0 Urinary Tract Infections

  • Key Trend
  • 13.1 Leading Cause of Morbidity and Death
    • 13.1.1 Impact
    • 13.1.2 Impact on Women
    • 13.1.3 E. coli the Key Culprit
  • 13.2 UTI Molecular Testing Market
  • 13.3 i-Health Inc.
  • 13.4 Liofilchem
  • 13.5 Rheonix
  • 13.6 Somagen Diagnostics

14.0 Neonatal Jaundice

  • Key Trend
  • 14.1 Issues Involving Bilirubin
  • 14.2 Two Factors in Neonates
  • 14.3 Risk Factors
  • 14.4 Smart Phone App
  • 14.5 Bilirubin Testing Market
  • 14.6 Instrumentation Laboratory
  • 14.7 Nova Biomedical
  • 14.8 Siemens Healthcare Diagnostics
  • 14.9 Wako Diagnostics
  • 14.10 Roche Diagnostics

15.0 Autoimmune Disease

  • Key Trend
  • 15.1 Types of Autoimmune Disease
  • 15.2 Genetic Factors
  • 15.3 Impact on Females
  • 15.4 Female Lab-Based Immunoassay Autoimmune Testing Market
  • 15.5 Aesku.Diagnostics
  • 15.6 AXA Diagnostics SRL
  • 15.7 Bio-Rad Laboratories
  • 15.8 Euroimmun AG
  • 15.9 Immco Diagnostics
  • 15.10 Kronus
  • 15.11 Phadia
  • 15.12 XDx

16.0 Cystic Fibrosis

  • Key Trend
  • 16.1 Affecting the Entire Body
  • 16.2 Reduced Life Expectancy
  • 16.3 Genetics
  • 16.4 Chronic Infections
  • 16.5 Females Worse Than Males
  • 16.6 Genetic Testing Market
  • 16.7 AutoGenomics
  • 16.8 GenMark Diagnostics
  • 16.9 Illumina
  • 16.10 Luminex
  • 16.11 ScheBo - Biotech AG
  • 16.12 Sequenom
Back to Top